INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
104 hedge funds and large institutions have $633M invested in Infinity Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
3.02%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
24
Increased
34
Reduced
33
Closed
20
Calls
$13.7M
Puts
$13.9M
Net Calls
-$212K
Net Calls Change
-$4.19M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$25M |
| 2 |
Goldman Sachs
New York
|
+$18.6M |
| 3 |
VAM
Visium Asset Management
New York
|
+$13.1M |
| 4 |
BC
Broadfin Capital
New York
|
+$9.75M |
| 5 |
Renaissance Technologies
New York
|
+$7.68M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.4M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$10.2M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.87M |
| 5 |
QF
QVT Financial
New York
|
-$8.36M |
